Short Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Declines By 5.4%

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) was the recipient of a significant decline in short interest in August. As of August 31st, there was short interest totalling 8,700 shares, a decline of 5.4% from the August 15th total of 9,200 shares. Based on an average daily trading volume, of 13,900 shares, the short-interest ratio is presently 0.6 days.

Hedge Funds Weigh In On ProShares Ultra Nasdaq Biotechnology

A number of institutional investors and hedge funds have recently added to or reduced their stakes in BIB. Clarity Capital Partners LLC acquired a new position in shares of ProShares Ultra Nasdaq Biotechnology during the fourth quarter worth approximately $201,000. Texas Capital Bank Wealth Management Services Inc acquired a new position in shares of ProShares Ultra Nasdaq Biotechnology during the first quarter worth approximately $288,000. Westwood Wealth Management acquired a new position in shares of ProShares Ultra Nasdaq Biotechnology during the first quarter worth approximately $575,000. Toth Financial Advisory Corp lifted its position in shares of ProShares Ultra Nasdaq Biotechnology by 132.3% during the first quarter. Toth Financial Advisory Corp now owns 26,111 shares of the exchange traded fund’s stock worth $1,502,000 after purchasing an additional 14,870 shares in the last quarter. Finally, IMC Chicago LLC acquired a new position in shares of ProShares Ultra Nasdaq Biotechnology during the fourth quarter worth approximately $2,435,000.

ProShares Ultra Nasdaq Biotechnology Stock Performance

NASDAQ:BIB opened at $67.26 on Wednesday. ProShares Ultra Nasdaq Biotechnology has a 12 month low of $40.10 and a 12 month high of $69.56. The company’s 50-day moving average price is $65.16 and its two-hundred day moving average price is $59.24.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 3rd. Shareholders of record on Wednesday, June 26th were given a $0.2648 dividend. The ex-dividend date of this dividend was Wednesday, June 26th. This is a positive change from ProShares Ultra Nasdaq Biotechnology’s previous quarterly dividend of $0.04. This represents a $1.06 dividend on an annualized basis and a yield of 1.57%.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.